FindTrial
Sign In

The Application of Cardiac Magnetic Resonance in the Diagnosis, Follow-up and Therapeutic Monitoring of Fabry Cardiomyopathy.

The Application of Cardiac Magnetic Resonance in the Diagnosis, Follow-up and Therapeutic Monitoring of Fabry Cardiomyopathy.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081484
Enrollment
Unknown
Registered
2024-03-01
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anderson-Fabry Cardiomyopathy

Interventions

Anderson-Fabry Cardiomyopathy group:none
control group:none

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients are selected with a certain diagnostic standard of Anderson–Fabry Disease. 2. All enrolled patients underwent standardized cardiovascular MRI. 3. Informed consent is obtained from all participants.

Exclusion criteria

Exclusion criteria: 1. Patients with age less than 18 years old are excluded. 2. Patients with poor CMR image quality

Design outcomes

Primary

MeasureTime frame
Diagnostic of Anderson–Fabry cardiomyopathy;Diagnostic of Anderson–Fabry cardiomyopathy;Diagnostic of Anderson–Fabry cardiomyopathy;—

Secondary

MeasureTime frame
Diagnostic of Anderson–Fabry cardiomyopathy;Diagnostic of Anderson–Fabry cardiomyopathy;—

Countries

China

Contacts

Public ContactJingfen Zhu

The First Affiliated Hospital of Soochow University

904564075@qq.com+86 188 9658 2133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026